Roche reports very strong sales growth in the first nine months of 2019 โ€“ outlook raised

Roche issued a press release on its nine month sales with the following headlines. Group sales increase 10% at constant exchange rates and 9% in Swiss francs, due to new products Pharmaceuticals Division sales up 12%, driven by high demand for recently launched medicines, mainly Ocrevus, Hemlibra, Tecentriq and Perjeta  Diagnostics Division sales grow 4%, primarily …